BHLHE40-mediated upregulation of CAV1 decreases the radiosensitivity of nasopharyngeal carcinoma
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.01069.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Ying Bin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China. Hauptthemen laut MEDLINE: Caveolin 1, Radiation Tolerance, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), the Joint Project on Regional High-Incidence Disease Research of the Guangxi Natural Science Foundation, The Research Foundation of the Science and Technology Department of Guangxi Province, China.
Abstract (Originalsprache)
This study reveals that BHLHE40 reduces NPC radiosensitivity by transcriptionally activating CAV1, which in turn activates the Akt pathway. In addition, CAV1-containing exosomes secreted by radioresistant NPC cells promote angiogenesis, further accelerating tumor progression. These findings provide new insights into the molecular mechanisms of NPC radioresistance and suggest that targeting CAV1 could be a promising therapeutic strategy to enhance radiosensitivity and improve treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
- Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
- Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent, Nanning, People's Republic of China.
- Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning, People's Republic of China.
- Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, People's Republic of China.
- State Key Laboratory of Targeting Oncology, Guangxi Medical University, Nanning, People's Republic of China.
ORCID-Profile: Li Jiang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- the Joint Project on Regional High-Incidence Disease Research of the Guangxi Natural Science Foundation
- The Research Foundation of the Science and Technology Department of Guangxi Province, China
- Guangxi Medical University Trainning Program for Distinguished Young Scholars 2017
- Medical Excellence Award Funded by the Creative Research Development Grant from the First Affiliated Hospital of Guangxi Medical University
Zitieren
APA
Bin, Y., Wu, L., Du, Y., Qiu, X., Huang, Y., Kang, M., & Jiang, L. (2025). BHLHE40-mediated upregulation of CAV1 decreases the radiosensitivity of nasopharyngeal carcinoma. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.01069.2024
Vancouver
Bin Y, Wu L, Du Y, Qiu X, Huang Y, Kang M, et al. BHLHE40-mediated upregulation of CAV1 decreases the radiosensitivity of nasopharyngeal carcinoma. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.01069.2024
BibTeX
@article{Bin2025,
author = {Bin, Ying and Wu, Lanhua and Du, Youchang and Qiu, Xingyue and Huang, Yaoyi and Kang, Min and Jiang, Li},
title = {BHLHE40-mediated upregulation of CAV1 decreases the radiosensitivity of nasopharyngeal carcinoma},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.01069.2024}
}
EUVIMED